Sales decline 1.74% to Rs 269.04 crore
Net profit of Marksans Pharma rose 97.60% to Rs 20.57 crore in the quarter ended September 2018 as against Rs 10.41 crore during the previous quarter ended September 2017. Sales declined 1.74% to Rs 269.04 crore in the quarter ended September 2018 as against Rs 273.81 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales269.04273.81 -2 OPM %13.808.98 -PBDT33.2621.55 54 PBT27.7214.57 90 NP20.5710.41 98Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
